Technical Analysis for INCR - Intercure Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 2.71 | 7.11% | 0.18 |
INCR closed up 7.11 percent on Thursday, March 28, 2024, on 1.67 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Apr 1
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Calm After Storm | Range Contraction | 7.11% | |
Wide Range Bar | Range Expansion | 7.11% | |
Upper Bollinger Band Walk | Strength | 7.11% |
Alert | Time |
---|---|
Rose Above Upper Bollinger Band | about 15 hours ago |
Up 5% | about 15 hours ago |
Possible Pocket Pivot | about 15 hours ago |
Up 1 ATR | about 15 hours ago |
Up 3% | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/01/2024
InterCure (dba Canndoc) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to maintain its position as Israel’s leading cannabis company as well as to drive further growth through global expansion.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cannabis Euphoriants Psychoactive Drugs Distribution Network Entheogens Medicinal Plants Cannabis Smoking Plants
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cannabis Euphoriants Psychoactive Drugs Distribution Network Entheogens Medicinal Plants Cannabis Smoking Plants
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.85 |
52 Week Low | 0.99 |
Average Volume | 97,752 |
200-Day Moving Average | 1.53 |
50-Day Moving Average | 1.77 |
20-Day Moving Average | 2.10 |
10-Day Moving Average | 2.33 |
Average True Range | 0.16 |
RSI (14) | 80.35 |
ADX | 38.06 |
+DI | 41.48 |
-DI | 18.76 |
Chandelier Exit (Long, 3 ATRs) | 2.28 |
Chandelier Exit (Short, 3 ATRs) | 2.13 |
Upper Bollinger Bands | 2.71 |
Lower Bollinger Band | 1.48 |
Percent B (%b) | 1.0 |
BandWidth | 58.56 |
MACD Line | 0.23 |
MACD Signal Line | 0.17 |
MACD Histogram | 0.0621 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.03 | ||||
Resistance 3 (R3) | 3.00 | 2.88 | 2.97 | ||
Resistance 2 (R2) | 2.88 | 2.80 | 2.89 | 2.95 | |
Resistance 1 (R1) | 2.79 | 2.75 | 2.84 | 2.82 | 2.94 |
Pivot Point | 2.67 | 2.67 | 2.69 | 2.68 | 2.67 |
Support 1 (S1) | 2.58 | 2.59 | 2.63 | 2.61 | 2.48 |
Support 2 (S2) | 2.46 | 2.54 | 2.47 | 2.47 | |
Support 3 (S3) | 2.37 | 2.46 | 2.45 | ||
Support 4 (S4) | 2.40 |